|
Q2 FY2026
As of Aug 2, 2026
|
Q1 FY2026
As of May 3, 2026
|
Q4 FY2025
As of Feb 1, 2026
|
Q3 FY2025
As of Nov 2, 2025
|
Q2 FY2025
As of Aug 3, 2025
|
Q1 FY2025
As of May 4, 2025
|
Q4 FY2024
As of Feb 2, 2025
|
Q3 FY2024
As of Oct 27, 2024
|
Q2 FY2024
As of Jul 28, 2024
|
Q1 FY2024
As of Apr 28, 2024
|
Q4 FY2023
As of Jan 28, 2024
|
Q3 FY2023
As of Oct 29, 2023
|
Q2 FY2023
As of Jul 30, 2023
|
Q1 FY2023
As of Apr 30, 2023
|
Q4 FY2022
As of Jan 29, 2023
|
Q3 FY2022
As of Oct 30, 2022
|
Q2 FY2022
As of Jul 31, 2022
|
Q1 FY2022
As of May 1, 2022
|
Q4 FY2021
As of Jan 30, 2022
|
Q3 FY2021
As of Oct 31, 2021
|
|
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Assets | ||||||||||||||||||||
| Current assets: | ||||||||||||||||||||
| Cash and cash equivalents | ||||||||||||||||||||
| Receivables, net | ||||||||||||||||||||
| Merchandise inventories | ||||||||||||||||||||
| Other current assets | ||||||||||||||||||||
| Total current assets | ||||||||||||||||||||
| Net property and equipment | ||||||||||||||||||||
| Operating lease right-of-use assets | ||||||||||||||||||||
| Goodwill | ||||||||||||||||||||
| Intangible assets, net | ||||||||||||||||||||
| Other assets | ||||||||||||||||||||
| Total assets | ||||||||||||||||||||
| Liabilities and Stockholders' Equity | ||||||||||||||||||||
| Current liabilities: | ||||||||||||||||||||
| Short-term debt | ||||||||||||||||||||
| Accounts payable | ||||||||||||||||||||
| Accrued salaries and related expenses | ||||||||||||||||||||
| Sales taxes payable | ||||||||||||||||||||
| Deferred revenue | ||||||||||||||||||||
| Income taxes payable | ||||||||||||||||||||
| Current installments of long-term debt | ||||||||||||||||||||
| Current operating lease liabilities | ||||||||||||||||||||
| Other accrued expenses | ||||||||||||||||||||
| Total current liabilities | ||||||||||||||||||||
| Long-term debt, excluding current installments | ||||||||||||||||||||
| Long-term operating lease liabilities | ||||||||||||||||||||
| Deferred income taxes | ||||||||||||||||||||
| Other long-term liabilities | ||||||||||||||||||||
| Total liabilities | ||||||||||||||||||||
| Common stock, par value $0.05; authorized: 10,000 shares; issued: 1,804 shares at August 2, 2026 and 1,802 shares at February 1, 2026; outstanding: 998 shares at August 2, 2026 and 996 shares at February 1, 2026 | ||||||||||||||||||||
| Paid-in capital | ||||||||||||||||||||
| Retained earnings | ||||||||||||||||||||
| Accumulated other comprehensive loss | ||||||||||||||||||||
| Treasury stock, at cost, 806 shares at August 2, 2026 and February 1, 2026 | ||||||||||||||||||||
| Total stockholders’ equity | ||||||||||||||||||||
| Total liabilities and stockholders’ equity |
Loading...
